Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-24

Clinical Trial Update: Ketamine Infusion for Neuropathic Pain in Brachial Plexus Injuries [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is updating enrollment for ketamine infusions to treat neuropathic pain in brachial plexus injury, with enrollment by invitation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ketamine (ketamine)

Snippet

Sponsor: Mayo Clinic | Conditions: Brachial Plexus Injury | Phase 4 | Status: ENROLLING_BY_INVITATION